Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Cell Death Discovery
|
June 17, 2026
Glucocorticoid-induced Leucine Zipper (GILZ) is a novel secreted protein by intestinal L-cells and is dysregulated during active ulcerative colitis
Lucrezia Rosati, Giuseppe Leoncini, Luigi Cari, et al.
Gut Microbes
|
March 19, 2026
A bile acid-GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis
Michele Biagioli, Cristina Di Giorgio, Silvia Marchianò, et al.
Translational Oncology
|
June 8, 2026
Pharmacological inhibition of LIF signaling reverses PD-L1-mediated immune suppression in gastric cancer
Cristina Di Giorgio, Silvia Marchianò, Michele Biagioli, et al.
Biochemistry and Biophysics Reports
|
June 8, 2026
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy
Cristina Di Giorgio, Michele Biagioli, Silvia Marchianò, et al.
Biochemical Pharmacology
|
January 16, 2026
LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma
Cristina Di Giorgio, Maria Rosaria Sette, Benedetta Sensini, et al.
Cells
|
February 26, 2026
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric Cancer
Cristina Di Giorgio, Nicola Natalizi, Maria Rosaria Sette, et al.
Hepatology Communications
|
August 26, 2025
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- mice
Cristina Di Giorgio, Ginevra Urbani, Carmen Massa, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Cell Death Discovery
|
June 17, 2026
Glucocorticoid-induced Leucine Zipper (GILZ) is a novel secreted protein by intestinal L-cells and is dysregulated during active ulcerative colitis
Lucrezia Rosati, Giuseppe Leoncini, Luigi Cari, et al.
Gut Microbes
|
March 19, 2026
A bile acid-GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis
Michele Biagioli, Cristina Di Giorgio, Silvia Marchianò, et al.
Translational Oncology
|
June 8, 2026
Pharmacological inhibition of LIF signaling reverses PD-L1-mediated immune suppression in gastric cancer
Cristina Di Giorgio, Silvia Marchianò, Michele Biagioli, et al.
Biochemistry and Biophysics Reports
|
June 8, 2026
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy
Cristina Di Giorgio, Michele Biagioli, Silvia Marchianò, et al.
Biochemical Pharmacology
|
January 16, 2026
LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma
Cristina Di Giorgio, Maria Rosaria Sette, Benedetta Sensini, et al.
Cells
|
February 26, 2026
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric Cancer
Cristina Di Giorgio, Nicola Natalizi, Maria Rosaria Sette, et al.
Hepatology Communications
|
August 26, 2025
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- mice
Cristina Di Giorgio, Ginevra Urbani, Carmen Massa, et al.
Page
of 1